Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vericel (VCEL) EBITDA: 2010-2025

Historic EBITDA for Vericel (VCEL) over the last 16 years, with Sep 2025 value amounting to $3.5 million.

  • Vericel's EBITDA rose 239.96% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 678.36%. This contributed to the annual value of $4.5 million for FY2024, which is 169.91% up from last year.
  • Vericel's EBITDA amounted to $3.5 million in Q3 2025, which was up 270.03% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, Vericel's EBITDA registered a high of $18.5 million during Q4 2024, and its lowest value of -$12.8 million during Q1 2025.
  • Its 3-year average for EBITDA is -$1.2 million, with a median of -$5.1 million in 2023.
  • In the last 5 years, Vericel's EBITDA tumbled by 241.06% in 2021 and then surged by 239.96% in 2025.
  • Over the past 5 years, Vericel's EBITDA (Quarterly) stood at $4.1 million in 2021, then soared by 46.95% to $6.1 million in 2022, then soared by 109.22% to $12.7 million in 2023, then spiked by 45.15% to $18.5 million in 2024, then soared by 239.96% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, -$2.0 million for Q2 2025, and -$12.8 million during Q1 2025.